Boston Scientific Corporation announced positive data from the TARGET study of the TheraSphere Y-90 Glass Microspheres (TheraSphere) – a type of radioembolization comprised of millions of microscopic glass beads containing radioactive yttrium (Y-90) – during a late-breaking clinical trial presentation at the annual scientific meeting for the Society of Interventional Radiology (SIR).
News | Interventional Radiology
Late-Breaking Clinical Trial Data for TheraSphere Y-90 Glass Microspheres Demonstrates Improved Survival in Primary Liver Cancer

March 25, 2021 — Boston Scientific Corporation announced positive data from the TARGET study of the TheraSphere Y-90 ...

Time March 25, 2021
Home
pediatric MRI brain imaging in children
News | Pediatric Imaging
Study Reveals Rates of Brain Abnormalities in Healthy Children

March 25, 2021 — A large study of brain magnetic resonance imaging (MRI) scans from 11,679 nine- and ten-year-old ...

Time March 25, 2021
Home
Sun Nuclear Corporation announced that Australia's Northern Sydney Cancer Centre (NSCC) is now a reference site for the SunCHECK Quality Management Platform.
News | Radiation Therapy
Northern Sydney Cancer Centre Partners with Sun Nuclear as Newest SunCHECK Platform Reference Site

March 25, 2021 — Sun Nuclear Corporation announced that Australia's Northern Sydney Cancer Centre (NSCC) is now a ...

Time March 25, 2021
Home
Thirona, an artificial intelligence (AI) software company specialising in medical image analysis, developed an AI algorithm that revolutionizes cystic fibrosis (CF) care. The new algorithm, coined PRAGMA-AI, allows for fast, automated analysis of CT scans of patients with CF to detect and quantify lung abnormalities related to CF
News | Artificial Intelligence
Thirona Launches AI Software for Cystic Fibrosis

March 24, 2021 — Thirona, an artificial intelligence (AI) software company specialising in medical image analysis ...

Time March 24, 2021
Home
Gadopiclenol is a high-relaxivity macrocyclic contrast agent used for magnetic resonance imaging (MRI)
News | Contrast Media
Gadopiclenol has Positive Results for Phase III Clinical Trials 

March 24, 2021 — Guerbet announced positive results from two Phase III clinical studies comparing the diagnostic ...

Time March 24, 2021
Home
RSIP Vision, a leading innovator in medical imaging through advanced artificial intelligence (AI) and computer vision solutions, announced an advanced joint segmentation tool for detailed, non-invasive planning of revision arthroplasty and other orthopedic procedures for patients with pre-existing metal implants.
News | Computed Tomography (CT)
RSIP Vision Unveils Metal Implant and Anatomical Segmentation Tool

March 24, 2021 — RSIP Vision, a leading innovator in medical imaging through advanced artificial intelligence (AI) and ...

Time March 24, 2021
Home
GE Healthcare announced 510(k) clearance from U.S. FDA for OEC 3D, a new surgical imaging system capable of 3-D and 2-D imaging. OEC 3D will set a standard for interoperative 3-D imaging with precise volumetric images for spine and orthopedic procedures. This new system combines the benefits and familiarity of 2-D imaging with greater efficiency to increase access and usability to 3-D.
News | Mobile C-Arms
GE Healthcare Announces 510(k) Clearance of New 3-D Surgical Imaging System

March 23, 2021 — GE Healthcare announced 510(k) clearance from U.S. FDA for OEC 3D, a new surgical imaging system ...

Time March 23, 2021
Home
The first known study exploring optimal outpatient exam scheduling through a model algorithm was shown to yield shorter wait times for magnetic resonance imaging (MRI) for patients and reduced costs. A collaboration including experts at Lahey Hospital & Medical Center (LHMC) and at the Thayer School of Engineering at Dartmouth College worked to identify sources of delays for MRI procedures at LHMC in order to develop a mathematical model to optimize scheduling.
News | Magnetic Resonance Imaging (MRI)
LHMC Radiology Team Reports on Model Algorithm to Optimize MRI Scheduling

March 23, 2021 — The first known study exploring optimal outpatient exam scheduling through a model algorithm was shown ...

Time March 23, 2021
Home
A new study led by Ivan Martinez—associate professor in the WVU School of Medicine and Cancer Institute—found a link between a family of RNAs, the Y chromosome, and radiation sensitivity in male lung-cancer patients
News | Radiation Therapy
Loss of Y chromosome, RNA Tied to Radiation Resistance in Male Lung-cancer Patients

March 23, 2021 — The science behind the COVID-19 vaccine has the potential to do more than prevent cases of COVID-19 ...

Time March 23, 2021
Home
Cancer tissue being bombarded by targeted alpha particles. The generator developed by Los Alamos National Laboratory holds uranium-230, which decays to thorium-226. Further decay produces short-lived daughter isotopes, emitting four more alpha particles resulting in a very high combined radiation dose to destroy cancer cells.
News | Radiation Therapy
New Los Alamos Generator System Delivers Large Radiation Doses Directly to Cancer Cells

March 23, 2021 — Improved options for cancer treatment are on the way, thanks to a new system developed at Los Alamos ...

Time March 23, 2021
Home
iCad announced that ProFound AI Version 3.0 for Digital Breast Tomosynthesis (DBT) was cleared by the U.S. Food and Drug Administration (FDA).
News | Breast Imaging
FDA Clears for ProFound AI Version 3.0 for 3D Mammography

March 23, 2021 — iCad announced that ProFound AI Version 3.0 for Digital Breast Tomosynthesis (DBT) was cleared by the U ...

Time March 23, 2021
Home
Detection of tumor-infiltrating lymphocytes (TILs) using explainable AI. The AI-technique is used to generate a heatmap showing TILs (red) and other tissues and cells (blue and green). Image courtesy of Klauschen/Charité
News | Artificial Intelligence
Making the Role of AI in Breast Cancer Explainable

March 22, 2021 — Researchers at Charité - Universitätsmedizin Berlin and TU Berlin as well as the University of Oslo ...

Time March 22, 2021
Home
The contrast agents global market is expected to grow at a high single digit CAGR from 2020 to 2027 to reach $7,033.5 million by 2027 due to the increasing incidence and prevalence of chronic diseases and demand for diagnostic and interventional radiology procedures, increase in aging population, expansion of contrast agent indications, the growth of medical imaging in the emerging market, increasing research activities and favorable reimbursement
News | Contrast Media
Contrast Media Agents Global Market

Chemical substances that improve the visibility of specific organs, tissues, or blood vessels during a diagnostic or ...

Time May 03, 2021
Home
The Moscow Center for Diagnostics and Telemedicine presented clinical research findings during ECR 2021 highlighting that full integration of AI into radiology workflow during the pandemic increased radiologists' productivity
News | Artificial Intelligence
Study Finds AI-powered COVID-19 Solution by RADlogics Reduces Turnaround Time

March 22, 2021 — Moscow Center for Diagnostics & Telemedicine and RADLogics shared the results of a large-scale study ...

Time March 22, 2021
Home
Many women suffering significant postpartum bleeding continue to receive hysterectomies, rather than uterine artery embolization (UAE), despite evidence that UAE results in reduced hospital stays and costs, and offers an opportunity to preserve fertility, according to new research to be presented at the Society of Interventional Radiology Annual Scientific Meeting
News | Interventional Radiology
Hysterectomy Used More for Postpartum Bleeding Compared to Less Invasive Option

March 19, 2021 — Many women suffering significant postpartum bleeding continue to receive hysterectomies, rather than ...

Time March 19, 2021
Home
Radiofrequency ablation for the palliative treatment of osseous metastases reduces pain and improves quality of life
News | Interventional Radiology
Minimally Invasive Treatment Provides Fast Pain Relief for Cancer Patients

March 19, 2021 — A minimally invasive treatment for patients whose cancer has spread to their bones provides quick and ...

Time March 19, 2021
Home
Videos | Magnetic Resonance Imaging (MRI)
VIDEO: Artificial Intelligence For MRI Helps Overcome Backlog of Exams Due to COVID

Darryl B. Sneag, M.D., a radiologist and director of peripheral nerve MRI at the Hospital for Special Surgery (HSS) in ...

Time March 19, 2021
Home
A non-surgical treatment for arthritis in the knee is safe and effective in providing immediate and long-term pain relief, according to a new study to be presented at the Society of Interventional Radiology Annual Scientific Meeting. Genicular artery embolization (GAE) reduces inflammation in the knee to improve function and quality of life for people with moderate to severe knee pain.
News | Interventional Radiology
Non-surgical Treatment Quickly Reduces Arthritis Knee Pain and Improves Function

March 19, 2021 — A non-surgical treatment for arthritis in the knee is safe and effective in providing immediate and ...

Time March 19, 2021
Home
Left to right: Subtraction right mediolateral oblique (MLO) CEM was non-diagnostic because of artifact, potentially due to motion misregistration from extended exposure time; subtraction right MLO implant displaced CEM image shows 5.8 cm enhancing mass (arrow); contrast-enhanced MRI sagittal subtraction image shows concordant mass (arrow).
News | Breast Imaging
Contrast-Enhanced Mammography for Breast Cancer in Women With Augmented Breasts

March 18, 2021 — According to ARRS’ American Journal of Roentgenology (AJR), contrast-enhanced mammography (CEM) showed ...

Time March 18, 2021
Home
Boston Scientific's TheraSphere Y-90 Glass Microspheres enable selective internal radiation therapy (SIRT), or radioembolization, for hepatocellular carcinoma. This treats liver cancer with low toxicity using millions of microscopic glass beads containing radioactive yttrium (Y-90), delivered directly to liver tumors via catheter. The result in minimal radiation exposure to surrounding healthy tissue.
News | Radiation Therapy
FDA Clears Boston Scientific TheraSphere Y-90 Transcatheter Liver Embolization Microspheres

March 18, 2021 — The U.S. Food and Drug Administration (FDA) has cleared Boston Scientific's TheraSphere Y-90 Glass ...

Time March 18, 2021
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now